ECM Therapeutics, developers of tissue repair gel Hydrogel and biotherapeutic agent Matrix- bound Nanovesicles, has raised $26M and hired a team of 7 at its Pittsburgh headquarters. Co-founders Stephen Badylak, DVM, PhD, MD and Katie Collins recognized the opportunity to unlock the healing power of the extracellular matrix to reduce inflammation and restore function to damaged tissue, muscle and nerve cells. With 40 issued patents and 90 patent applications pending, ECM is strategically positioned to develop products in multiple clinical markets including gastrointestinal, musculoskeletal, optic and central nervous system.
